We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
Sensus Healthcare, Inc. (SRTS - Free Report) closed at $3.45 in the latest trading session, marking a -2.82% move from the prior day. This change lagged the S&P 500's 0.58% gain on the day.
Coming into today, shares of the company had gained 8.56% in the past month. In that same time, the Medical sector gained 2.74%, while the S&P 500 gained 3.68%.
Investors will be eagerly watching for the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. The company is forecasted to report an EPS of -$0.12, showcasing a 271.43% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $4.64 million, indicating a 47.51% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.43 per share and revenue of $26.34 million. These totals would mark changes of -204.88% and -37%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Sensus Healthcare, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 62.26% lower. Sensus Healthcare, Inc. is currently sporting a Zacks Rank of #5 (Strong Sell).
The Medical - Instruments industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 90, placing it within the top 37% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
Sensus Healthcare, Inc. (SRTS - Free Report) closed at $3.45 in the latest trading session, marking a -2.82% move from the prior day. This change lagged the S&P 500's 0.58% gain on the day.
Coming into today, shares of the company had gained 8.56% in the past month. In that same time, the Medical sector gained 2.74%, while the S&P 500 gained 3.68%.
Investors will be eagerly watching for the performance of Sensus Healthcare, Inc. in its upcoming earnings disclosure. The company is forecasted to report an EPS of -$0.12, showcasing a 271.43% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $4.64 million, indicating a 47.51% downward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.43 per share and revenue of $26.34 million. These totals would mark changes of -204.88% and -37%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Sensus Healthcare, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 62.26% lower. Sensus Healthcare, Inc. is currently sporting a Zacks Rank of #5 (Strong Sell).
The Medical - Instruments industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 90, placing it within the top 37% of over 250 industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.